G1 Therapeutics, Inc.
GTHXDelisted Sep 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001560241
G1 Therapeutics, Inc. was delisted on Sep 18, 2024; its insiders filed their last Form 4 on Sep 18, 2024; 88 institutions reported holding it in 13F filings for Q2 2024, worth $45.5M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in G1 Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- +7 vs. Q4 2021
- Shares held
- 24.2M
- −2.33M (−8.8%) vs. Q4 2021
- Total value
- $183.8M
- −$86.8M (−32.1%) vs. Q4 2021
- New holders
- 18
- 27 more added
- Sold out
- 11
- 45 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GTHX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 88 | $45.5M |
| Q1 2024 | 86 | $61.6M |
| Q4 2023 | 87 | $38.5M |
| Q3 2023 | 72 | $15.8M |
| Q2 2023 | 80 | $38.6M |
| Q1 2023 | 97 | $51.5M |
| Q4 2022 | 116 | $125.1M |
| Q3 2022 | 104 | $287.5M |
| Q2 2022 | 98 | $98.2M |
| Q1 2022 | 115 | $183.8M |
| Q4 2021 | 108 | $270.6M |
| Q3 2021 | 115 | $357.8M |
| Q2 2021 | 114 | $541.8M |
| Q1 2021 | 123 | $582.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding G1 Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tekla Capital Management LLC | 423,869 | $3.22M | 0.11% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 445,137 | $3.38M | 0.00% | +61,185+15.9% | Added |
| FMR LLC | 487,725 | $3.71M | 0.00% | +377,586+342.8% | Added |
| CHI Advisors LLC | 488,635 | $3.71M | 1.58% | +258,635+112.5% | Added |
| Lombard Odier Asset Management (Switzerland) SA | 542,183 | $4.12M | 0.32% | −507,764−48.4% | Reduced |
| Dimensional Fund Advisors LP | 566,011 | $4.30M | 0.00% | +41,278+7.9% | Added |
| Geode Capital Management, LLC | 668,140 | $5.08M | 0.00% | −47,233−6.6% | Reduced |
| MPM Oncology Impact Management LP | 856,798 | $6.51M | 1.75% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,923,704 | $14.6M | 0.00% | −620,661−24.4% | Reduced |
| JPMorgan Chase & Co | 2,097,753 | $15.9M | 0.00% | −45,931−2.1% | Reduced |
| Fisher Asset Management, LLC | 2,311,138 | $17.6M | 0.01% | +43,064+1.9% | Added |
| BlackRock Inc. | 3,299,849 | $25.1M | 0.00% | −10,363−0.3% | Reduced |
| State Street Corp | 3,676,814 | $27.9M | 0.00% | −624,799−14.5% | Reduced |
| Advisor Group Holdings, Inc. | 908 | – | – | +350+62.7% | Added |
| Aaron Wealth Advisors | 1,641 | – | – | +1,641 | New |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −50,394−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −33,859−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −20,418−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −19,400−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −12,667−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,716−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −772−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −479−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −376−100.0% | Sold out |